Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice: amelioration of clinical, histologic, and radiologic signs of type II collagen-induced arthritis.
Joosten LA, Coenen-de Roo CJ, Helsen MM, Lubberts E, Boots AM, van den Berg WB, Miltenburg AM. Joosten LA, et al. Among authors: boots am. Arthritis Rheum. 2000 Mar;43(3):645-55. doi: 10.1002/1529-0131(200003)43:3<645::AID-ANR22>3.0.CO;2-O. Arthritis Rheum. 2000. PMID: 10728759 Free article.
Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.
van Lierop MJ, den Hoed L, Houbiers J, Vencovsky J, Ruzickova S, Krystufkova O, van Schaardenburg M, van den Hoogen F, Vandooren B, Baeten D, De Keyser F, Sønderstrup G, Bos E, Boots AM. van Lierop MJ, et al. Among authors: boots am. Arthritis Rheum. 2007 Jul;56(7):2150-9. doi: 10.1002/art.22651. Arthritis Rheum. 2007. PMID: 17599744 Free article.
Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation.
Boots AM, Hubers H, Kouwijzer M, den Hoed-van Zandbrink L, Westrek-Esselink BM, van Doorn C, Stenger R, Bos ES, van Lierop MJ, Verheijden GF, Timmers CM, van Staveren CJ. Boots AM, et al. Arthritis Res Ther. 2007;9(4):R71. doi: 10.1186/ar2269. Arthritis Res Ther. 2007. PMID: 17645792 Free PMC article.
Therapeutic antibody targeting of CD97 in experimental arthritis: the role of antigen expression, shedding, and internalization on the pharmacokinetics of anti-CD97 monoclonal antibody 1B2.
de Groot DM, Vogel G, Dulos J, Teeuwen L, Stebbins K, Hamann J, Owens BM, van Eenennaam H, Bos E, Boots AM. de Groot DM, et al. Among authors: boots am. J Immunol. 2009 Sep 15;183(6):4127-34. doi: 10.4049/jimmunol.0901253. Epub 2009 Aug 28. J Immunol. 2009. PMID: 19717518 Free article.
PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer.
Dulos J, Carven GJ, van Boxtel SJ, Evers S, Driessen-Engels LJ, Hobo W, Gorecka MA, de Haan AF, Mulders P, Punt CJ, Jacobs JF, Schalken JA, Oosterwijk E, van Eenennaam H, Boots AM. Dulos J, et al. Among authors: boots am. J Immunother. 2012 Feb-Mar;35(2):169-78. doi: 10.1097/CJI.0b013e318247a4e7. J Immunother. 2012. PMID: 22306905
122 results